Grants and Contributions:
Agreement Number:
-
Agreement Value:
$696,150.00
Agreement Date:
Apr 1, 2017 - Mar 31, 2022
Description:
Improving treatment efficacy: A randomized controlled trial of the combined used of intranasal oxytocin and cognitive behavioral therapy for the treatment of major depressive disorder
Organization:
Canadian Institutes of Health Research
Location:
Montreal, Quebec, CA H3G 1M8
Reference Number:
236-2017-2018-Q1-00155
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:
Grant or Award spanning more than one fiscal year.
(2017-18 to 2021-22)
Recipient's Legal Name:
Ellenbogen, Mark A
Research Organization:
Concordia University (Montreal, Quebec)|Université Concordia